rs186430430

This is a intron variant variant in the CHEK2 gene.

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

Ovarian cyst

Allele T
OR 0.65
p 7.0e-15
N 232,058
Large GWAS
European

neutrophil count

Allele C
OR
p 1.0e-10
N 627,215
Large GWAS
multi-ancestry

anti-Mullerian hormone measurement

Allele C
OR 0.79
p 2.0e-9
N 9,668
Meta-analysis
European

platelet crit

Allele C
OR 0.23
p 6.0e-9
N 164,339
Large GWAS
European

leukocyte quantity

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele T
OR 0.30
p 1.0e-18
N 381,267
Major Consortium StudyLarge GWAS
European

prostate specific antigen amount

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele T
OR 0.27
p 6.0e-12
N 254,502
Major Consortium StudyLarge GWAS
European

thyroid carcinoma

Allele C
OR 0.92
p 5.0e-12
N 2,917,628
Large GWAS
multi-ancestry

About CHEK2

In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

View all CHEK2 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…